|
||||||
|
 | |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
|
Gene: ENSG00000129824 |
Summary for RPS4Y1 |
 Gene summary |
| Gene information | Ensembl ID | ENSG00000129824 | Gene symbol | RPS4Y1 |
| Gene name | ribosomal protein S4 Y-linked 1 | |
| HGNC | 10425 | |
| Entrez ID | 6192 | |
| Gene type | protein_coding | |
| Synonyms | RPS4Y1|MGC5070|MGC119100|S4 | |
| UniProtAcc | P22090 |
| Drugs associated with this gene(DrugBank). |
| Gene ID | Gene Symbol | Drug ID | Drug Name | Drug Type |
| Cancer therapeutic drugs associated with this gene(NCI). |
| Gene ID | Gene Name | Drug ID | Drug Name | Drug Type | Cancer |
Top |
Structure and expression level for RPS4Y1 |
| AS events and RNA A-to-I editing events of the gene in TCGA based on Genvode V22 structure. ∗For more information on exon skipping events please check the ExonskipDB database. ∗For more information on exon skipping events please check the CAeditome database. |
 |
| Landscape of gene expressions across multiple cancer types. |
 |
| Differentially expressed gene analysis between tumor male and tumor female samples. |
 |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| RPS4Y1 | 1.68e+02 | 1.15e+01 | 1.53e+00 | 7.54e+00 | 4.73e-14 | 5.64e-11 | BRCA |
| RPS4Y1 | 4.90e+03 | 7.69e+00 | 1.71e-01 | 4.49e+01 | 0.00e+00 | 0.00e+00 | LGG |
| RPS4Y1 | 7.67e+03 | 9.43e+00 | 1.62e-01 | 5.84e+01 | 0.00e+00 | 0.00e+00 | SKCM |
| RPS4Y1 | 6.35e+03 | 1.03e+01 | 2.33e-01 | 4.42e+01 | 0.00e+00 | 0.00e+00 | SARC |
| RPS4Y1 | 3.51e+03 | 9.14e+00 | 2.34e-01 | 3.92e+01 | 0.00e+00 | 0.00e+00 | PCPG |
| RPS4Y1 | 3.95e+03 | 7.28e+00 | 2.99e-01 | 2.44e+01 | 2.56e-131 | 1.50e-127 | PAAD |
| RPS4Y1 | 3.48e+03 | 7.79e+00 | 3.27e-01 | 2.38e+01 | 3.76e-125 | 8.12e-122 | READ |
| RPS4Y1 | 4.75e+03 | 8.97e+00 | 3.83e-01 | 2.34e+01 | 2.20e-121 | 1.34e-117 | ESCA |
| RPS4Y1 | 2.88e+03 | 1.15e+01 | 1.87e-01 | 6.16e+01 | 0.00e+00 | 0.00e+00 | LAML |
| RPS4Y1 | 1.22e+04 | 9.94e+00 | 2.08e-01 | 4.79e+01 | 0.00e+00 | 0.00e+00 | THYM |
| RPS4Y1 | 1.14e+04 | 9.42e+00 | 3.49e-01 | 2.70e+01 | 1.06e-160 | 6.06e-157 | MESO |
| RPS4Y1 | 7.68e+03 | 9.86e+00 | 5.00e-01 | 1.97e+01 | 1.27e-86 | 6.52e-83 | UVM |
| RPS4Y1 | 3.24e+03 | 1.07e+01 | 4.54e-01 | 2.35e+01 | 2.98e-122 | 2.59e-118 | ACC |
| RPS4Y1 | 6.82e+03 | 9.12e+00 | 4.50e-01 | 2.03e+01 | 3.27e-91 | 1.90e-87 | DLBC |
| RPS4Y1 | 5.55e+03 | 1.05e+01 | 4.97e-01 | 2.11e+01 | 1.92e-98 | 1.05e-94 | CHOL |
| RPS4Y1 | 5.70e+03 | 6.06e+00 | 1.33e-01 | 4.54e+01 | 0.00e+00 | 0.00e+00 | GBM |
| Differentially expressed gene analysis between tumor male and normal male samples. |
 |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| RPS4Y1 | 5.92e+03 | -1.11e+00 | 2.95e-01 | -3.77e+00 | 1.64e-04 | 5.68e-04 | STAD |
| RPS4Y1 | 4.03e+03 | -1.21e+00 | 3.91e-01 | -3.09e+00 | 1.98e-03 | 3.96e-03 | KIRP |
| Differentially expressed gene analysis between tumor female and normal female samples. |
 |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| RPS4Y1 | 3.69e+01 | 3.46e+00 | 6.56e-01 | 5.28e+00 | 1.31e-07 | 5.49e-07 | KIRC |
Top |
Sex-biased somatic mutation for RPS4Y1 |
| ∗For more information on exon skipping events please check the ExonskipDB database. |
| Gene ID | Cancer Type | Hugo Symbol | Male | Female | pval | or | ci.up | ci.low | adjPval |
Top |
DNA methylation with beta values for RPS4Y1 |
| Landscape of DNA methylation across multiple cancer types. |
 |
| Differentially expressed CpG sites between male tumor and female tumor patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| BRCA | cg08673225 | chrY:2840931 | CGI:chrY:2789761-2790058 | promoter | 2.75e-02 | 8.67e-01 | 3.69e+00 | 2.21e-04 | 3.27e-03 | -8.40e-01 |
| LUAD | cg01311227 | chrY:2841586 | CGI:chrY:2789761-2790058 | UTR,promoter,exon,gene body | 8.92e-01 | 1.04e-01 | 1.87e+01 | 1.16e-77 | 7.73e-76 | 7.88e-01 |
| SKCM | cg25443613 | chrY:2841564 | CGI:chrY:2789761-2790058 | UTR,promoter,exon,gene body | 1.91e-01 | 7.15e-02 | 1.65e+01 | 8.34e-61 | 1.53e-59 | 1.20e-01 |
| KIRP | cg08673225 | chrY:2840931 | CGI:chrY:2789761-2790058 | promoter | 4.89e-01 | 8.34e-01 | 5.09e+00 | 3.65e-07 | 4.08e-06 | -3.45e-01 |
| ACC | cg01311227 | chrY:2841586 | CGI:chrY:2789761-2790058 | UTR,promoter,exon,gene body | 5.43e-01 | 2.03e-01 | 7.29e+00 | 3.12e-13 | 6.40e-12 | 3.40e-01 |
| ACC | cg01375382 | chrY:2841557 | CGI:chrY:2789761-2790058 | UTR,promoter,exon,gene body | 6.22e-01 | 3.03e-01 | 6.55e+00 | 5.90e-11 | 7.52e-10 | 3.19e-01 |
| ACC | cg08673225 | chrY:2840931 | CGI:chrY:2789761-2790058 | promoter | 5.03e-01 | 7.23e-01 | -5.91e+00 | 3.35e-09 | 3.51e-08 | -2.20e-01 |
| ACC | cg25443613 | chrY:2841564 | CGI:chrY:2789761-2790058 | UTR,promoter,exon,gene body | 4.83e-01 | 1.52e-01 | 7.24e+00 | 4.52e-13 | 8.72e-12 | 3.31e-01 |
| Differentially expressed CpG sites between male tumor and male normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| COAD | cg01375382 | chrY:2841557 | CGI:chrY:2789761-2790058 | UTR,promoter,exon,gene body | 2.78e-01 | 1.53e-01 | 2.23e+00 | 2.56e-02 | 3.00e-02 | 1.25e-01 |
| COAD | cg25443613 | chrY:2841564 | CGI:chrY:2789761-2790058 | UTR,promoter,exon,gene body | 1.90e-01 | 7.39e-02 | 2.04e+00 | 4.09e-02 | 4.29e-02 | 1.16e-01 |
| Differentially expressed CpG sites between female tumor and female normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
Top |
Exon skipping events with PSI in TCGA for RPS4Y1 |
| ∗Please access ExonSkipDB for exon skipping annotation. |
| Landscape of exon skipping events across multiple cancer types. |
 |
| Differentially expressed exon skipping events between male tumor and female tumor patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
| Differentially expressed exon skipping events between male tumor and male normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
| Differentially expressed exon skipping events between female tumor and female normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Top |
RNA A-to-I editing events in TCGA for RPS4Y1 |
| ∗Please access CAeditome for RNA editing annotation. |
| Differentially expressed RNA editing events between male tumor and female tumor patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Differentially expressed RNA editing events between male tumor and male normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Differentially expressed RNA editing events between female tumor and female normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Protein coding RNA editing(s). |
| Editing Position | Variant Type | Gene Symbol | Transcript ID | NTchange | AAchange |
Top |
Sex-biased TF-Gene network for RPS4Y1 |
| TFs related to RPS4Y1. ∗The female-biased TF-gene edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased TF-gene edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
 |
| Cancer Type | TF | Target Gene | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| BRCA | ATOH1 | RPS4Y1 | 3.10e+00 | 3.36e-03 | 4.65e+00 | 9.89e-01 | Female-biased |
| BRCA | GLI3 | RPS4Y1 | 2.67e+00 | 2.75e-03 | 4.28e+00 | 9.83e-01 | Female-biased |
| BRCA | GLIS2 | RPS4Y1 | 2.20e+00 | 1.26e-04 | 4.71e+00 | 9.93e-01 | Female-biased |
| BRCA | GLIS3 | RPS4Y1 | 3.14e+00 | 1.59e-03 | 4.95e+00 | 9.94e-01 | Female-biased |
| BRCA | MEIS3 | RPS4Y1 | 3.58e+00 | 8.67e-03 | 4.84e+00 | 9.86e-01 | Female-biased |
| BRCA | MYOG | RPS4Y1 | 3.51e+00 | 2.80e-03 | 5.13e+00 | 9.94e-01 | Female-biased |
| BRCA | NR3C1 | RPS4Y1 | 4.49e+00 | 5.33e-03 | 5.92e+00 | 9.94e-01 | Female-biased |
| BRCA | PKNOX1 | RPS4Y1 | 3.90e+00 | 1.44e-02 | 5.00e+00 | 9.81e-01 | Female-biased |
| BRCA | PKNOX2 | RPS4Y1 | 3.59e+00 | 8.65e-03 | 4.85e+00 | 9.86e-01 | Female-biased |
| BRCA | PLAGL2 | RPS4Y1 | 1.88e+00 | 3.34e-05 | 4.68e+00 | 9.93e-01 | Female-biased |
| BRCA | PTF1A | RPS4Y1 | 3.17e+00 | 7.35e-03 | 4.48e+00 | 9.82e-01 | Female-biased |
| BRCA | SPZ1 | RPS4Y1 | 1.75e+00 | 1.34e-04 | 4.24e+00 | 9.84e-01 | Female-biased |
| BRCA | TCF21 | RPS4Y1 | 3.13e+00 | 2.04e-03 | 4.85e+00 | 9.93e-01 | Female-biased |
| BRCA | TFAP4 | RPS4Y1 | 2.08e+00 | 5.81e-04 | 4.17e+00 | 9.82e-01 | Female-biased |
| BRCA | TGIF2 | RPS4Y1 | 3.85e+00 | 1.01e-02 | 5.07e+00 | 9.86e-01 | Female-biased |
| BRCA | THRB | RPS4Y1 | 3.72e+00 | 8.26e-03 | 4.99e+00 | 9.88e-01 | Female-biased |
| BRCA | USF1 | RPS4Y1 | 2.71e+00 | 2.97e-03 | 4.30e+00 | 9.83e-01 | Female-biased |
| BRCA | ZNF331 | RPS4Y1 | 1.72e+00 | 1.46e-04 | 4.19e+00 | 9.83e-01 | Female-biased |
| BRCA | ZNF431 | RPS4Y1 | 2.13e+00 | 3.95e-04 | 4.34e+00 | 9.87e-01 | Female-biased |
| GBM | GLIS3 | RPS4Y1 | 2.87e+00 | 5.15e-03 | 4.18e+00 | 9.84e-01 | Female-biased |
| GBM | MEIS3 | RPS4Y1 | 3.33e+00 | 9.36e-03 | 4.41e+00 | 9.84e-01 | Female-biased |
| GBM | MYOG | RPS4Y1 | 3.49e+00 | 1.03e-02 | 4.53e+00 | 9.84e-01 | Female-biased |
| GBM | PKNOX2 | RPS4Y1 | 3.59e+00 | 1.35e-02 | 4.53e+00 | 9.81e-01 | Female-biased |
| GBM | PTF1A | RPS4Y1 | 2.92e+00 | 5.46e-03 | 4.20e+00 | 9.85e-01 | Female-biased |
| GBM | TCF21 | RPS4Y1 | 2.92e+00 | 6.56e-03 | 4.12e+00 | 9.82e-01 | Female-biased |
| LAML | FOXC1 | RPS4Y1 | 3.86e+00 | 2.40e-03 | 5.13e+00 | 9.94e-01 | Female-biased |
| LAML | FOXF1 | RPS4Y1 | 3.60e+00 | 1.72e-03 | 4.95e+00 | 9.94e-01 | Female-biased |
| LAML | FOXF2 | RPS4Y1 | 4.46e+00 | 7.02e-03 | 5.46e+00 | 9.91e-01 | Female-biased |
| LAML | FOXI1 | RPS4Y1 | 4.22e+00 | 4.27e-03 | 5.34e+00 | 9.93e-01 | Female-biased |
| LAML | FOXJ2 | RPS4Y1 | 3.02e+00 | 3.26e-03 | 4.20e+00 | 9.83e-01 | Female-biased |
| LAML | FOXK2 | RPS4Y1 | 4.17e+00 | 7.01e-03 | 5.17e+00 | 9.90e-01 | Female-biased |
| LAML | FOXP2 | RPS4Y1 | 3.50e+00 | 1.98e-03 | 4.81e+00 | 9.93e-01 | Female-biased |
| LAML | FOXQ1 | RPS4Y1 | 3.53e+00 | 4.25e-03 | 4.66e+00 | 9.89e-01 | Female-biased |
| LAML | GFI1B | RPS4Y1 | 3.65e+00 | 9.47e-03 | 4.56e+00 | 9.83e-01 | Female-biased |
| LAML | HOXA6 | RPS4Y1 | 5.82e+00 | 1.39e-02 | 6.63e+00 | 9.86e-01 | Female-biased |
| LAML | IRF1 | RPS4Y1 | 3.23e+00 | 2.71e-03 | 4.47e+00 | 9.88e-01 | Female-biased |
| LAML | IRF2 | RPS4Y1 | 3.49e+00 | 6.68e-03 | 4.49e+00 | 9.85e-01 | Female-biased |
| LAML | IRF4 | RPS4Y1 | 4.54e+00 | 8.08e-03 | 5.50e+00 | 9.90e-01 | Female-biased |
| LAML | MEIS2 | RPS4Y1 | 4.41e+00 | 1.40e-02 | 5.23e+00 | 9.83e-01 | Female-biased |
| LAML | MYF6 | RPS4Y1 | 4.77e+00 | 6.76e-03 | 5.78e+00 | 9.92e-01 | Female-biased |
| LAML | SKOR1 | RPS4Y1 | 4.29e+00 | 5.12e-03 | 5.37e+00 | 9.93e-01 | Female-biased |
| LAML | SKOR2 | RPS4Y1 | 4.47e+00 | 9.21e-03 | 5.39e+00 | 9.89e-01 | Female-biased |
| LAML | SPI1 | RPS4Y1 | 3.06e+00 | 4.83e-04 | 4.71e+00 | 9.93e-01 | Female-biased |
| LAML | SPIB | RPS4Y1 | 2.90e+00 | 6.79e-04 | 4.47e+00 | 9.91e-01 | Female-biased |
| LAML | YY1 | RPS4Y1 | 4.01e+00 | 1.07e-02 | 4.89e+00 | 9.85e-01 | Female-biased |
| LAML | ZNF146 | RPS4Y1 | 3.33e+00 | 3.64e-03 | 4.49e+00 | 9.88e-01 | Female-biased |
| LAML | ZNF250 | RPS4Y1 | 3.86e+00 | 2.48e-03 | 5.12e+00 | 9.94e-01 | Female-biased |
| LAML | ZNF3 | RPS4Y1 | 3.08e+00 | 4.70e-03 | 4.16e+00 | 9.81e-01 | Female-biased |
| LAML | ZNF74 | RPS4Y1 | 3.81e+00 | 8.96e-03 | 4.74e+00 | 9.85e-01 | Female-biased |
| LGG | GLIS2 | RPS4Y1 | 4.50e+00 | 8.66e-03 | 5.02e+00 | 9.88e-01 | Female-biased |
| LGG | GLIS3 | RPS4Y1 | 4.69e+00 | 1.37e-02 | 5.13e+00 | 9.84e-01 | Female-biased |
| LGG | HOXA6 | RPS4Y1 | 5.67e+00 | 1.55e-02 | 6.10e+00 | 9.84e-01 | Female-biased |
| LGG | MEIS2 | RPS4Y1 | 4.40e+00 | 9.83e-03 | 4.91e+00 | 9.86e-01 | Female-biased |
| LGG | MYOG | RPS4Y1 | 4.32e+00 | 8.65e-03 | 4.84e+00 | 9.87e-01 | Female-biased |
| LGG | NR3C1 | RPS4Y1 | 5.22e+00 | 7.41e-03 | 5.77e+00 | 9.91e-01 | Female-biased |
| LGG | PTF1A | RPS4Y1 | 4.16e+00 | 9.48e-03 | 4.67e+00 | 9.85e-01 | Female-biased |
| MESO | FOXI1 | RPS4Y1 | 4.55e+00 | 9.80e-01 | 3.43e+00 | 1.34e-02 | Male-biased |
| PAAD | SPI1 | RPS4Y1 | 4.22e+00 | 9.84e-01 | 3.29e+00 | 5.85e-03 | Male-biased |
| PCPG | FOXC1 | RPS4Y1 | 3.31e+00 | 3.85e-03 | 4.33e+00 | 9.88e-01 | Female-biased |
| PCPG | FOXF2 | RPS4Y1 | 3.91e+00 | 9.16e-03 | 4.73e+00 | 9.87e-01 | Female-biased |
| PCPG | FOXK2 | RPS4Y1 | 3.63e+00 | 6.45e-03 | 4.53e+00 | 9.88e-01 | Female-biased |
| PCPG | FOXP2 | RPS4Y1 | 2.81e+00 | 2.64e-03 | 3.89e+00 | 9.81e-01 | Female-biased |
| PCPG | MYF6 | RPS4Y1 | 4.42e+00 | 1.15e-02 | 5.20e+00 | 9.86e-01 | Female-biased |
| PCPG | SKOR1 | RPS4Y1 | 3.63e+00 | 5.43e-03 | 4.57e+00 | 9.89e-01 | Female-biased |
| PCPG | SKOR2 | RPS4Y1 | 3.88e+00 | 6.84e-03 | 4.77e+00 | 9.89e-01 | Female-biased |
| SARC | ATOH1 | RPS4Y1 | 3.96e+00 | 1.10e-02 | 4.59e+00 | 9.84e-01 | Female-biased |
| SARC | CDX1 | RPS4Y1 | 9.02e+00 | 1.90e-02 | 9.55e+00 | 9.81e-01 | Female-biased |
| SARC | CDX4 | RPS4Y1 | 8.08e+00 | 1.82e-02 | 8.62e+00 | 9.82e-01 | Female-biased |
| SARC | FOXC1 | RPS4Y1 | 3.42e+00 | 8.89e-05 | 4.97e+00 | 9.97e-01 | Female-biased |
| SARC | FOXF1 | RPS4Y1 | 3.04e+00 | 7.88e-05 | 4.61e+00 | 9.95e-01 | Female-biased |
| SARC | FOXF2 | RPS4Y1 | 3.92e+00 | 2.20e-04 | 5.29e+00 | 9.98e-01 | Female-biased |
| SARC | FOXI1 | RPS4Y1 | 3.79e+00 | 7.09e-04 | 4.93e+00 | 9.96e-01 | Female-biased |
| SARC | FOXK2 | RPS4Y1 | 3.67e+00 | 2.59e-04 | 5.01e+00 | 9.97e-01 | Female-biased |
| SARC | FOXP2 | RPS4Y1 | 2.89e+00 | 9.49e-05 | 4.42e+00 | 9.93e-01 | Female-biased |
| SARC | FOXQ1 | RPS4Y1 | 2.69e+00 | 8.11e-05 | 4.25e+00 | 9.90e-01 | Female-biased |
| SARC | GFI1B | RPS4Y1 | 3.51e+00 | 1.50e-03 | 4.50e+00 | 9.92e-01 | Female-biased |
| SARC | HOXA11 | RPS4Y1 | 9.25e+00 | 1.84e-02 | 9.79e+00 | 9.82e-01 | Female-biased |
| SARC | HOXA6 | RPS4Y1 | 5.55e+00 | 1.95e-03 | 6.50e+00 | 9.98e-01 | Female-biased |
| SARC | HOXB9 | RPS4Y1 | 6.30e+00 | 2.30e-03 | 7.22e+00 | 9.97e-01 | Female-biased |
| SARC | HOXC12 | RPS4Y1 | 8.54e+00 | 1.40e-02 | 9.13e+00 | 9.86e-01 | Female-biased |
| SARC | HOXC9 | RPS4Y1 | 7.56e+00 | 6.65e-03 | 8.28e+00 | 9.93e-01 | Female-biased |
| SARC | HOXD10 | RPS4Y1 | 8.74e+00 | 1.30e-02 | 9.34e+00 | 9.87e-01 | Female-biased |
| SARC | HOXD9 | RPS4Y1 | 7.35e+00 | 6.42e-03 | 8.08e+00 | 9.93e-01 | Female-biased |
| SARC | IRF1 | RPS4Y1 | 2.63e+00 | 1.02e-04 | 4.14e+00 | 9.89e-01 | Female-biased |
| SARC | IRF2 | RPS4Y1 | 3.26e+00 | 4.04e-04 | 4.50e+00 | 9.93e-01 | Female-biased |
| SARC | IRF4 | RPS4Y1 | 4.55e+00 | 2.92e-03 | 5.42e+00 | 9.95e-01 | Female-biased |
| SARC | MEIS2 | RPS4Y1 | 4.35e+00 | 1.59e-03 | 5.33e+00 | 9.97e-01 | Female-biased |
| SARC | MYF6 | RPS4Y1 | 4.74e+00 | 1.25e-03 | 5.78e+00 | 9.98e-01 | Female-biased |
| SARC | MYOG | RPS4Y1 | 4.13e+00 | 3.71e-03 | 4.95e+00 | 9.93e-01 | Female-biased |
| SARC | NR3C1 | RPS4Y1 | 5.08e+00 | 7.39e-03 | 5.78e+00 | 9.92e-01 | Female-biased |
| SARC | PKNOX1 | RPS4Y1 | 4.39e+00 | 1.18e-02 | 5.01e+00 | 9.85e-01 | Female-biased |
| SARC | PKNOX2 | RPS4Y1 | 4.26e+00 | 1.49e-02 | 4.84e+00 | 9.81e-01 | Female-biased |
| SARC | PLAGL2 | RPS4Y1 | 4.42e+00 | 9.91e-01 | 3.36e+00 | 5.64e-04 | Male-biased |
| SARC | PTF1A | RPS4Y1 | 3.96e+00 | 9.12e-03 | 4.62e+00 | 9.86e-01 | Female-biased |
| SARC | SKOR1 | RPS4Y1 | 3.69e+00 | 3.42e-04 | 4.97e+00 | 9.97e-01 | Female-biased |
| SARC | SKOR2 | RPS4Y1 | 3.96e+00 | 4.52e-04 | 5.19e+00 | 9.97e-01 | Female-biased |
| SARC | SPI1 | RPS4Y1 | 2.98e+00 | 6.25e-04 | 4.14e+00 | 9.88e-01 | Female-biased |
| SARC | SPIB | RPS4Y1 | 2.93e+00 | 1.66e-03 | 3.89e+00 | 9.81e-01 | Female-biased |
| SARC | TBX18 | RPS4Y1 | 3.87e+00 | 6.10e-03 | 4.60e+00 | 9.89e-01 | Female-biased |
| SARC | TCF21 | RPS4Y1 | 4.02e+00 | 7.95e-03 | 4.71e+00 | 9.88e-01 | Female-biased |
| SARC | TGIF1 | RPS4Y1 | 4.50e+00 | 8.89e-03 | 5.17e+00 | 9.89e-01 | Female-biased |
| SARC | TGIF2 | RPS4Y1 | 4.43e+00 | 1.17e-02 | 5.05e+00 | 9.86e-01 | Female-biased |
| SARC | TGIF2LX | RPS4Y1 | 4.51e+00 | 1.13e-02 | 5.13e+00 | 9.86e-01 | Female-biased |
| SARC | YY1 | RPS4Y1 | 3.59e+00 | 5.12e-04 | 4.80e+00 | 9.96e-01 | Female-biased |
| SARC | ZNF146 | RPS4Y1 | 2.51e+00 | 1.55e-04 | 3.93e+00 | 9.84e-01 | Female-biased |
| SARC | ZNF250 | RPS4Y1 | 3.49e+00 | 2.68e-04 | 4.82e+00 | 9.96e-01 | Female-biased |
| SARC | ZNF3 | RPS4Y1 | 2.65e+00 | 4.82e-04 | 3.85e+00 | 9.81e-01 | Female-biased |
| SARC | ZNF331 | RPS4Y1 | 3.98e+00 | 9.82e-01 | 3.08e+00 | 1.31e-03 | Male-biased |
| SARC | ZNF74 | RPS4Y1 | 3.57e+00 | 1.04e-03 | 4.63e+00 | 9.94e-01 | Female-biased |
| SKCM | FOXC1 | RPS4Y1 | 5.09e+00 | 9.86e-01 | 3.98e+00 | 8.49e-03 | Male-biased |
| SKCM | FOXF1 | RPS4Y1 | 5.01e+00 | 9.90e-01 | 3.65e+00 | 4.05e-03 | Male-biased |
| SKCM | FOXF2 | RPS4Y1 | 5.39e+00 | 9.85e-01 | 4.40e+00 | 1.22e-02 | Male-biased |
| SKCM | FOXI1 | RPS4Y1 | 5.29e+00 | 9.86e-01 | 4.24e+00 | 1.03e-02 | Male-biased |
| SKCM | FOXK2 | RPS4Y1 | 5.09e+00 | 9.82e-01 | 4.12e+00 | 1.26e-02 | Male-biased |
| SKCM | FOXP2 | RPS4Y1 | 4.63e+00 | 9.82e-01 | 3.48e+00 | 7.33e-03 | Male-biased |
| SKCM | FOXQ1 | RPS4Y1 | 4.81e+00 | 9.89e-01 | 3.34e+00 | 2.85e-03 | Male-biased |
| SKCM | IRF1 | RPS4Y1 | 4.59e+00 | 9.84e-01 | 3.32e+00 | 5.09e-03 | Male-biased |
| SKCM | SKOR1 | RPS4Y1 | 5.45e+00 | 9.92e-01 | 4.18e+00 | 5.50e-03 | Male-biased |
| SKCM | SKOR2 | RPS4Y1 | 5.55e+00 | 9.90e-01 | 4.40e+00 | 7.64e-03 | Male-biased |
| SKCM | ZNF146 | RPS4Y1 | 4.53e+00 | 9.83e-01 | 3.26e+00 | 5.06e-03 | Male-biased |
| SKCM | ZNF250 | RPS4Y1 | 4.93e+00 | 9.83e-01 | 3.90e+00 | 1.06e-02 | Male-biased |
| THYM | ELF4 | RPS4Y1 | 4.27e+00 | 9.84e-01 | 3.45e+00 | 5.47e-03 | Male-biased |
| THYM | FOXC1 | RPS4Y1 | 3.40e+00 | 5.67e-03 | 4.22e+00 | 9.82e-01 | Female-biased |
| THYM | FOXF1 | RPS4Y1 | 2.94e+00 | 1.98e-03 | 4.01e+00 | 9.82e-01 | Female-biased |
| THYM | FOXF2 | RPS4Y1 | 3.84e+00 | 4.40e-03 | 4.73e+00 | 9.90e-01 | Female-biased |
| THYM | FOXI1 | RPS4Y1 | 3.81e+00 | 8.89e-03 | 4.53e+00 | 9.83e-01 | Female-biased |
| THYM | FOXK2 | RPS4Y1 | 3.72e+00 | 6.90e-03 | 4.50e+00 | 9.85e-01 | Female-biased |
| THYM | MEIS3 | RPS4Y1 | 3.71e+00 | 8.03e-03 | 4.45e+00 | 9.83e-01 | Female-biased |
| THYM | MYF6 | RPS4Y1 | 4.41e+00 | 6.13e-03 | 5.22e+00 | 9.91e-01 | Female-biased |
| THYM | MYOG | RPS4Y1 | 3.61e+00 | 3.17e-03 | 4.58e+00 | 9.90e-01 | Female-biased |
| THYM | NR3C1 | RPS4Y1 | 4.43e+00 | 4.78e-03 | 5.31e+00 | 9.93e-01 | Female-biased |
| THYM | NRF1 | RPS4Y1 | 4.46e+00 | 9.92e-01 | 2.55e+00 | 6.54e-05 | Male-biased |
| THYM | PKNOX2 | RPS4Y1 | 3.76e+00 | 8.32e-03 | 4.49e+00 | 9.83e-01 | Female-biased |
| THYM | PTF1A | RPS4Y1 | 3.35e+00 | 5.80e-03 | 4.17e+00 | 9.81e-01 | Female-biased |
| THYM | SKOR1 | RPS4Y1 | 3.80e+00 | 7.68e-03 | 4.55e+00 | 9.85e-01 | Female-biased |
| THYM | SKOR2 | RPS4Y1 | 3.96e+00 | 6.48e-03 | 4.75e+00 | 9.88e-01 | Female-biased |
| THYM | TCF21 | RPS4Y1 | 3.30e+00 | 2.97e-03 | 4.29e+00 | 9.86e-01 | Female-biased |
| THYM | TGIF1 | RPS4Y1 | 4.15e+00 | 1.41e-02 | 4.75e+00 | 9.80e-01 | Female-biased |
| THYM | ZNF250 | RPS4Y1 | 3.29e+00 | 4.07e-03 | 4.19e+00 | 9.83e-01 | Female-biased |
| THYM | ZNF74 | RPS4Y1 | 3.34e+00 | 5.18e-03 | 4.18e+00 | 9.82e-01 | Female-biased |
| UVM | FOXF2 | RPS4Y1 | 4.89e+00 | 9.84e-01 | 3.40e+00 | 6.97e-03 | Male-biased |
| UVM | PLAGL2 | RPS4Y1 | 2.11e+00 | 4.81e-04 | 4.70e+00 | 9.89e-01 | Female-biased |
| UVM | SKOR1 | RPS4Y1 | 4.68e+00 | 9.82e-01 | 3.13e+00 | 6.06e-03 | Male-biased |
| UVM | SKOR2 | RPS4Y1 | 4.84e+00 | 9.82e-01 | 3.42e+00 | 8.03e-03 | Male-biased |
| RPS4Y1 related gene. ∗Only the gene encode TF might with this result. ∗For more information please check Sex-biased TF-Coding gene network. |
Top |
Sex-biased RBP-ES network for RPS4Y1 |
| RBPs related to ES in RPS4Y1. ∗The female-biased RBP-ES edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased RBP-ES edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
| Cancer Type | RBP | Target ES | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| RPS4Y1 related ES. ∗Only the gene encode RBP might with this result. ∗For more information please check Sex-biased RBP-ES network in cancer. |
Top |
Sex-biased CeRNA regulation of gene |
| Sex-biased CeRNA regulation of gene. |
| Gene ID | ceRNA(lncRNA-miRNA-mRNA) | Group | Cancer Type |
Top |
Sex-biased eQTL regulation of gene |
| Sex-biased eQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| eQTL | Description |
| Male-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| Female-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| Opposite sex-biased eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Sex-biased Gene in Cancer | Cancer Type |
Top |
Sex-biased eQTM regulation of gene |
| Sex-biased eQTM regulation of gene (The figures only show the pairs with FDR<1e-5. For more information please check the below table). |
| eQTM | Description |
| Male-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| Female-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| Opposite sex-biased eQTM regulation. |
| CpG Site | CpG Postion | CpG Island | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Male Cor | Male P-value | Female Cor | Female P-value | Sex-biased Coding Gene | Cancer Type |
Top |
Sex-biased sQTL regulation of gene |
| Sex-biased sQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTL | Description |
| Male-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
| Female-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
| Opposite sex-biased sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Male Effect | Male FDR | Female Effect | Female FDR | Cancer Type |
Top |
Sex-biased sQTM regulation of gene |
| Sex-biased sQTM regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTM | Description |
| Male-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
| Female-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
| Opposite sex-biased sQTM regulation. |
| EX ID | EX Info | Skipped Exon | CPG Site | CPG Position | CPG Island | Position to EX Events | Male Effect | Male FDR | Female Effect | Female FDR | Male Correlation | Male P-value | Female Correlation | Female P-value | ORF_anno | Cancer Type |
Top |
Related disease information of RPS4Y1 |
| Diseases associated with this gene (DisGeNET). |
| Gene ID | Gene Symbol | Disease ID | Disease Name | Number of PMID | Source |
